154 related articles for article (PubMed ID: 12637330)
21. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
22. Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport.
Reuter TY; Medhurst AL; Waisfisz Q; Zhi Y; Herterich S; Hoehn H; Gross HJ; Joenje H; Hoatlin ME; Mathew CG; Huber PA
Exp Cell Res; 2003 Oct; 289(2):211-21. PubMed ID: 14499622
[TBL] [Abstract][Full Text] [Related]
23. A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.
Kupfer G; Naf D; Garcia-Higuera I; Wasik J; Cheng A; Yamashita T; Tipping A; Morgan N; Mathew CG; D'Andrea AD
Exp Hematol; 1999 Apr; 27(4):587-93. PubMed ID: 10210316
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation of fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway.
Qiao F; Mi J; Wilson JB; Zhi G; Bucheimer NR; Jones NJ; Kupfer GM
J Biol Chem; 2004 Oct; 279(44):46035-45. PubMed ID: 15299017
[TBL] [Abstract][Full Text] [Related]
25. Fanconi anaemia proteins: major roles in cell protection against oxidative damage.
Pagano G; Youssoufian H
Bioessays; 2003 Jun; 25(6):589-95. PubMed ID: 12766948
[TBL] [Abstract][Full Text] [Related]
26. Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.
Galimi F; Noll M; Kanazawa Y; Lax T; Chen C; Grompe M; Verma IM
Blood; 2002 Oct; 100(8):2732-6. PubMed ID: 12351379
[TBL] [Abstract][Full Text] [Related]
27. Human alpha spectrin II and the FANCA, FANCC, and FANCG proteins bind to DNA containing psoralen interstrand cross-links.
McMahon LW; Sangerman J; Goodman SR; Kumaresan K; Lambert MW
Biochemistry; 2001 Jun; 40(24):7025-34. PubMed ID: 11401546
[TBL] [Abstract][Full Text] [Related]
28. The Fanconi anemia core complex forms four complexes of different sizes in different subcellular compartments.
Thomashevski A; High AA; Drozd M; Shabanowitz J; Hunt DF; Grant PA; Kupfer GM
J Biol Chem; 2004 Jun; 279(25):26201-9. PubMed ID: 15082718
[TBL] [Abstract][Full Text] [Related]
29. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality.
Pang Q; Christianson TA; Keeble W; Diaz J; Faulkner GR; Reifsteck C; Olson S; Bagby GC
Blood; 2001 Sep; 98(5):1392-401. PubMed ID: 11520787
[TBL] [Abstract][Full Text] [Related]
30. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
[TBL] [Abstract][Full Text] [Related]
31. The Fanconi anemia core complex associates with chromatin during S phase.
Mi J; Kupfer GM
Blood; 2005 Jan; 105(2):759-66. PubMed ID: 15256425
[TBL] [Abstract][Full Text] [Related]
32. Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia.
Pulliam-Leath AC; Ciccone SL; Nalepa G; Li X; Si Y; Miravalle L; Smith D; Yuan J; Li J; Anur P; Orazi A; Vance GH; Yang FC; Hanenberg H; Bagby GC; Clapp DW
Blood; 2010 Oct; 116(16):2915-20. PubMed ID: 20606166
[TBL] [Abstract][Full Text] [Related]
33. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway.
Medhurst AL; Huber PA; Waisfisz Q; de Winter JP; Mathew CG
Hum Mol Genet; 2001 Feb; 10(4):423-9. PubMed ID: 11157805
[TBL] [Abstract][Full Text] [Related]
34. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
[TBL] [Abstract][Full Text] [Related]
35. Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance.
Wilson JB; Blom E; Cunningham R; Xiao Y; Kupfer GM; Jones NJ
Mutat Res; 2010 Jul; 689(1-2):12-20. PubMed ID: 20450923
[TBL] [Abstract][Full Text] [Related]
36. [Progress of research on protein composition and gene therapy of Fanconi anaemia - review].
Li ZY; Zou YF; Deng YB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):231-5. PubMed ID: 15157341
[TBL] [Abstract][Full Text] [Related]
37. Molecular pathogenesis of fanconi anemia.
Taniguchi T; Dandrea AD
Int J Hematol; 2002 Feb; 75(2):123-8. PubMed ID: 11939257
[TBL] [Abstract][Full Text] [Related]
38. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA.
Waisfisz Q; de Winter JP; Kruyt FA; de Groot J; van der Weel L; Dijkmans LM; Zhi Y; Arwert F; Scheper RJ; Youssoufian H; Hoatlin ME; Joenje H
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10320-5. PubMed ID: 10468606
[TBL] [Abstract][Full Text] [Related]
39. Cytoplasmic FANCA-FANCC complex interacts and stabilizes the cytoplasm-dislocalized leukemic nucleophosmin protein (NPMc).
Du W; Li J; Sipple J; Chen J; Pang Q
J Biol Chem; 2010 Nov; 285(48):37436-44. PubMed ID: 20864535
[TBL] [Abstract][Full Text] [Related]
40. Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations.
Bouchlaka C; Abdelhak S; Amouri A; Ben Abid H; Hadiji S; Frikha M; Ben Othman T; Amri F; Ayadi H; Hachicha M; Rebaï A; Saad A; Dellagi K;
J Hum Genet; 2003; 48(7):352-61. PubMed ID: 12827451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
